Seite - 14 - in Advances in Neuroimmunology
Bild der Seite - 14 -
Text der Seite - 14 -
BrainSci. 2016,6, 19
8. Tomasik, J.;Rahmoune,H.;Guest,P.C.;Bahn,S.Neuroimmunebiomarkers inschizophrenia.Schizophr. Res.
2014. inpress.
9. Shie,F.S.;Chen,Y.H.;Chen,C.H.;Ho, I.K.Neuroimmunepharmacologyofneurodegenerativeandmental
diseases. J.NeuroimmunePharmacol. 2011,6, 28–40. [CrossRef] [PubMed]
10. Gottfried,C.;Bambini-Junior,V.;Francis,F.;Riesgo,R.;Savino,W.The impactofneuroimmunealterations
inautismspectrumdisorder.Front. Psychiatry2015. [CrossRef] [PubMed]
11. Hein,A.M.;O’Banion,M.K.Neuroinflammationandcognitivedysfunction inchronicdiseaseandaging.
J.NeuroimmunePharmacol. 2012,7, 3–6. [CrossRef] [PubMed]
12. Patterson,S.L.Immunedysregulationandcognitivevulnerabilityintheagingbrain: Interactionsofmicroglia,
IL-1β,BDNFandsynapticplasticity.Neuropharmacology2015,96, 11–18. [CrossRef] [PubMed]
13. Eichenbaum,H.Hippocampus:Cognitiveprocessesandneural representations thatunderliedeclarative
memory.Neuron2004,44, 109–120. [CrossRef] [PubMed]
14. Di Filippo,M.; Chiasserini, D.; Gardoni, F.; Viviani, B.; Tozzi, A.; Giampa, C.; Costa, C.; Tantucci,M.;
Zianni, E.; Boraso,M.; et al. Effects of central and peripheral inflammation on hippocampal synaptic
plasticity.Neurobiol.Dis. 2013,52, 229–236. [CrossRef] [PubMed]
15. Zink,W.E.;Anderson,E.;Boyle, J.;Hock,L.;Rodriguez-Sierra, J.;Xiong,H.;Gendelman,H.E.;Persidsky,Y.
Impairedspatial cognitionandsynapticpotentiation inamurinemodelofhumanimmunodeficiencyvirus
type1encephalitis. J.Neurosci. 2002,22, 2096–2105. [PubMed]
16. Savanthrapadian, S.; Wolff, A.R.; Logan, B.J.; Eckert, M.J.; Bilkey, D.K.; Abraham, W.C. Enhanced
hippocampalneuronalexcitabilityandLTPpersistenceassociatedwithreducedbehavioralflexibility in the
maternal immuneactivationmodelofschizophrenia.Hippocampus2013,23, 1395–1409. [CrossRef] [PubMed]
17. Mosayebi,G.; Soleyman,M.R.;Khalili,M.;Mosleh,M.;Palizvan,M.R.Changes insynaptic transmission
andlong-termpotentiation inductionasapossiblemechanismfor learningdisability inananimalmodelof
multiplesclerosis. Int.Neurourol. J.2016,20, 26–32. [CrossRef] [PubMed]
18. Fernandez-Fernandez,D.;Dorner-Ciossek,C.;Kroker,K.S.;Rosenbrock,H.Age-relatedsynapticdysfunction
in tg2576micestartsasa failure inearly long-termpotentiationwhichdevelops intoa fullabolishmentof
late long-termpotentiation. J.Neurosci. Res. 2016,94, 266–281. [CrossRef] [PubMed]
19. Imamura,Y.;Wang,H.;Matsumoto,N.;Muroya,T.;Shimazaki, J.;Ogura,H.;Shimazu,T. Interleukin-1β
causes long-termpotentiationdeficiency inamousemodelof septicencephalopathy.Neuroscience2011,187,
63–69. [CrossRef] [PubMed]
20. Batti,L.;O’Connor, J.J.Tumornecrosis factor-α impairs therecoveryofsynaptic transmissionfromhypoxia
inrathippocampalslices. J.Neuroimmunol. 2010,218, 21–27. [CrossRef] [PubMed]
21. Rossi, S.; Motta, C.; Studer, V.; Barbieri, F.; Buttari, F.; Bergami, A.; Sancesario, G.; Bernardini, S.; de
Angelis,G.;Martino,G.; et al.Tumornecrosis factor iselevated inprogressivemultiplesclerosisandcauses
excitotoxicneurodegeneration.Mult. Scler. 2014,20, 304–312. [CrossRef] [PubMed]
22. Bateup,H.S.; Johnson,C.A.;Denefrio,C.L.; Saulnier, J.L.;Kornacker,K.;Sabatini,B.L.Excitatory/inhibitory
synaptic imbalance leads tohippocampalhyperexcitability inmousemodelsof tuberoussclerosis.Neuron
2013,78, 510–522. [CrossRef] [PubMed]
23. Costa, C.; Sgobio, C.; Siliquini, S.; Tozzi, A.; Tantucci,M.; Ghiglieri, V.; di Filippo,M.; Pendolino, V.;
de Iure,A.;Marti,M.; et al.Mechanismsunderlyingthe impairmentofhippocampal long-termpotentiation
andmemory inexperimentalParkinson’sdisease.Br. J.Neurol. 2012,135, 1884–1899. [CrossRef] [PubMed]
24. Scott-McKean, J.J.;Costa,A.C.ExaggeratedNMDAmediatedLTDinamousemodelofdownsyndrome
andpharmacological rescuingbymemantine.Learn.Mem. 2011,18, 774–778. [CrossRef] [PubMed]
25. Roberto,M.;Nelson,T.E.;Ur,C.L.;Gruol,D.L.Long-termpotentiation in therathippocampus is reversibly
depressedbychronic intermittentethanolexposure. J.Neurophysiol. 2002,87, 2385–2397. [PubMed]
26. Biber,K.;Pinto-Duarte,A.;Wittendorp,M.C.;Dolga,A.M.;Fernandes,C.C.;vonFrijtagDrabbeKunzel, J.;
Keijser, J.N.;deVries,R.; Ijzerman,A.P.;Ribeiro, J.A.; et al. Interleukin-6upregulatesneuronaladenosine
A1receptors: Implications forneuromodulationandneuroprotection.Neuropsychopharmacology2008,33,
2237–2250. [CrossRef] [PubMed]
27. Penkowa,M.; Giralt,M.; Lago,N.; Camats, J.; Carrasco, J.; Hernandez, J.;Molinero,A.; Campbell, I.L.;
Hidalgo, J.Astrocyte-targetedexpressionof IL-6protects theCNSagainsta focalbrain injury.Exp.Neurol.
2003,181, 130–148. [CrossRef]
14
zurück zum
Buch Advances in Neuroimmunology"
Advances in Neuroimmunology
- Titel
- Advances in Neuroimmunology
- Autor
- Donna Gruol
- Herausgeber
- MDPI
- Ort
- Basel
- Datum
- 2017
- Sprache
- englisch
- Lizenz
- CC BY-NC-ND 4.0
- ISBN
- 978-3-03842-571-7
- Abmessungen
- 17.0 x 24.0 cm
- Seiten
- 164
- Schlagwörter
- neuroimmune, cytokine, chemokine, glia cel, neuron, neurodevelopment, neuroimmune disorder, neurologic disease, psychiatric disease, neuronal injury
- Kategorie
- Medizin